Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Juan Jaen Insider Profile
4 Followers
Juan Jaen, SVP, Drug Discovery & CSO at ChemoCentryx, holds 1.52M shares in Arcus Biosciences (Ticker: RCUS), holds 30.00K shares in ChemoCentryx (Ticker: CCXI).
Juan Jaen ChemoCentryx (CCXI)SVP, Drug Discovery & CSO
ChemoCentryx (CCXI)
SVP, Drug Discovery & CSO
Ranked #2,306 out of 97,983 Corporate Insiders
Profitable Transactions
5 out of 8 Profitable Transactions
Average Return
+62.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
President
Roles that Juan Jaen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Juan Jaen
Juan Jaen's Trading History
ChemoCentryx
Mar 11, 2013
―
Uninformative Sell
39.03K
$1.56M
Arcus Biosciences
Jun 18, 2024
President
Uninformative Sell
118.26K
$21.50M
List of latest transactions for each holding click on a transaction to see Juan Jaen's performance on stock
You May Also Like
Juan Jaen insider profile FAQ
What is the percentage of profitable transactions made by Juan Jaen?
The percentage of profitable transactions made by Juan Jaen is 63%.
What is the average return per transaction made by Juan Jaen?
The average return per transaction made by Juan Jaen is 62.50%.
What stocks does Juan Jaen hold?
Juan Jaen holds: CCXI, RCUS stocks.
What was Juan Jaen’s latest transaction?
Juan Jaen latest transaction was an Uninformative Sell of $118.26K.
What was Juan Jaen's most profitable transaction?
Juan Jaen’s most profitable transaction was an Informative Buy of RCUS stock on June 4, 2019. The return on the trade was 274.60%.
What is Juan Jaen's role in ChemoCentryx?
Juan Jaen's role in ChemoCentryx is SVP, Drug Discovery & CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.